انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers
Manage episode 403294720 series 2829082
Dr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
206 حلقات
Manage episode 403294720 series 2829082
Dr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
206 حلقات
ทุกตอน
×![Artwork](/static/images/128pixel.png)
1 Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials 18:03
![Artwork](/static/images/128pixel.png)
1 Yannick Romero on the changing landscape of national cancer control plans 24:40
![Artwork](/static/images/128pixel.png)
1 M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries 22:15
![Artwork](/static/images/128pixel.png)
1 Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma 15:07
![Artwork](/static/images/128pixel.png)
1 Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination 17:21
![Artwork](/static/images/128pixel.png)
1 May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics 40:45
![Artwork](/static/images/128pixel.png)
1 Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) 13:22
![Artwork](/static/images/128pixel.png)
1 Emmy Boerrigter on dose selection of novel anticancer drugs 11:41
![Artwork](/static/images/128pixel.png)
1 Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations 36:56
![Artwork](/static/images/128pixel.png)
1 Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment 24:08
![Artwork](/static/images/128pixel.png)
1 James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean 35:05
![Artwork](/static/images/128pixel.png)
1 Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials 11:22
![Artwork](/static/images/128pixel.png)
1 Maria Kyrgiou on innovations in gynaecological cancers and global disparities 25:42
![Artwork](/static/images/128pixel.png)
1 Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers 34:43
![Artwork](/static/images/128pixel.png)
1 Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer 16:06
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.